Vertex Pharmaceuticals Inc
SWB:VX1
Vertex Pharmaceuticals Inc
SWB:VX1
Price:
408.05
EUR
-1.79%
Market Closed
Market Cap:
€48.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Vertex Pharmaceuticals Inc
SWB:VX1
|
US |
|
C
|
CNFinance Holdings Ltd
NYSE:CNF
|
CN |
|
G
|
Globant SA
F:2G2
|
LU |
Intrinsic Value
The intrinsic value for 
Vertex Pharmaceuticals Inc (VX1) under the Base Case is 361.15 EUR.
Compared with the current market price of 408.05 EUR, the stock appears
Overvalued by 11% .
Intrinsic value calculated using
DCF
€361.15
Other reference points
Do our valuations actually work? See backtest results .
VX1
Intrinsic Value
€361.15
Overvaluation 11%
Monitor VX1
Get notified when the price drops
Free account · No credit card required
Track Buy Zone
20% below Intrinsic Value €288.92
Get notified when the price drops into your buy zone
Or choose another margin of safety
0% below
Intrinsic Value
10% below
Intrinsic Value
30% below
Intrinsic Value
40% below
Intrinsic Value
50% below
Intrinsic Value
Custom
Choose margin of safety
Alternatives to VX1
Fundamental Analysis
Financials
Revenue & Expenses Breakdown
Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Inc
Efficiency
Earnings Waterfall
Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Inc
What is the Intrinsic Value of one VX1 stock?
The intrinsic value for Vertex Pharmaceuticals Inc (VX1) under the Base Case is 361.15 EUR.
Is VX1 stock undervalued or overvalued?
Compared with the current market price of 408.05 EUR, the stock appears Overvalued by 11% .